HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Do butalbital-containing products have a role in the management of migraine?

AbstractSTUDY OBJECTIVE:
To evaluate the role of butalbital-containing products in the management of migraine.
METHODS:
Qualitative systematic search using MEDLINE (January 1966-November 2001), review of the United States Headache Consortium's evidence-based guidelines for migraine treatment, and review of other pertinent literature.
RESULTS:
Over 28 million people suffer with migraine, yet this illness is less than optimally diagnosed and managed. Between 14% and 36% of diagnosed migraineurs are prescribed butalbital-containing products, often as initial therapy. However, the only identified controlled trial of these drugs for migraine treatment showed that butalbital-containing products were inferior to butorphanol. The consortium's guidelines specifically discourage administration of butalbital-containing products for migraine. In addition, other published literature highlights the frequent adverse consequences of butalbital-containing products for migraineurs, such as poor migraine control, disability, drug-induced headaches, and withdrawal symptoms.
CONCLUSION:
Although butalbital-containing products commonly are prescribed for migraine, no evidence in the literature demonstrates their benefit over other agents or placebo. Drugs with proven migraine efficacy, as listed in the consortium's evidence-based guidelines, should be prescribed instead.
AuthorsRichard G Wenzel, Carrie A Sarvis
JournalPharmacotherapy (Pharmacotherapy) Vol. 22 Issue 8 Pg. 1029-35 (Aug 2002) ISSN: 0277-0008 [Print] United States
PMID12173787 (Publication Type: Journal Article, Review)
Chemical References
  • Analgesics
  • Barbiturates
  • Drug Combinations
  • butalbital
Topics
  • Analgesics (therapeutic use)
  • Barbiturates (therapeutic use)
  • Drug Combinations
  • Drug Utilization
  • Humans
  • Migraine Disorders (drug therapy)
  • Practice Guidelines as Topic
  • Tension-Type Headache (drug therapy)
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: